Summary
Aspial Lifestyle Limited, formerly known as Maxi-Cash Financial Services Corporation Limited, began with its first pawnshop in 2009 and was listed on SGX Catalist on 22 June 2012. Maxi-Cash is the first publicly listed pawnbroker in Singapore, providing pawnbroking services through its MaxiCash brand. Aspial Lifestyle now operates a diversified portfolio of consumer brands across retail, pawnbroking, and secured lending, with a presence in Singapore and Malaysia. Its portfolio includes established names such as Maxi-Cash, Goldheart, Lee Hwa and BigFundr in Singapore, as well as Dr.Pajak and Dr.Emas in Malaysia. Transfer to Mainboard. The recent transfer to the SGX Mainboard on 4 May 2026 serves as a major liquidity and visibility catalyst. The transfer removes a significant technical barrier for institutional funds whose investment mandates strictly prohibit exposure to the Catalist board. Following the SGX-ST's in-principle approval, the company was required to satisfy stringent public float and market capitalisation prerequisites to facilitate the listing transfer. To achieve compliance while simultaneously fuelling its aggressive expansion roadmap, the company executed a meticulously planned equity fund-raising programme. The private placement was heavily oversubscribed, attracting a formidable roster of blue-chip institutional investors, including Eastspring Investments (Singapore) Limited, ICH Synergrowth Fund, Lion Global Investors Limited, Value Partners Hong Kong Limited and an insurance-based asset management company. Equity Fund Raising and Capital Deployment. Aspial Lifestyle successfully completed an S$84.8 million equity fundraising exercise, comprising an S$60 million private placement and an S$ 24.8 million nonrenounceable preferential offering, priced at S$0.402 per share. The utilisation of this fresh capital is explicitly earmarked to accelerate growth across the ecosystem. Approximately 80% of the gross proceeds, amounting to roughly S$67.8 million, will be directed towards general corporate activities encompassing business expansion, investments in the rapidly growing pawnbroking and secured lending segments, and potential strategic acquisitions. Excluding fees and expenses of S$1.7 million, the remaining funds are allocated for working capital requirements and the strategic repayment of existing bank borrowings, thereby improving the group's leverage ratios. Aggressive Malaysian Expansion. In March 2026, Aspial Lifestyle announced a major regional acquisition involving Ion World, Kedai Emas Ion, and Focus Resources in Malaysia. This suite of acquisitions represents a calculated push to capture market share in the rapidly expanding Malaysian pawnbroking and retail sector, predominantly centred around the state of Johor. Ion World operates the Dr.Pajak brand, which is celebrated for pioneering the first drive-through pawnshop model in Malaysia, a significant operational innovation catering to customer convenience and discretion in a highly automobile-dependent demographic.
More on Aspial Lifestyle Limited
This report has been prepared and distributed by SAC Capital Private Limited (“SAC Capital”) which is a holder of a capital markets services licence and an exempt financial adviser in Singapore. This report is provided for general information only and is not intended to constitute investment, legal, tax or accounting advice. It has been prepared without regard to the specific investment objectives, financial situation, tax position or particular needs of any individual person or specific group. Nothing in this report constitutes a solicitation, invitation or offer to buy or sell any securities. Prospective investors should conduct their own due diligence and obtain independent advice (including from a financial adviser) as to the suitability of any investment, taking into account their personal circumstances. This report is confidential and is provided solely for the recipient’s information. The contents of this report may not be copied, reproduced, published, distributed or transmitted (in part or in whole) to any other person without the prior written consent of SAC Capital. The distribution of this report outside the jurisdiction of Singapore is also strictly prohibited. Recipients are responsible for complying with any such restrictions. No representation is made that this report may be lawfully distributed in compliance with any applicable regulations outside Singapore. Whereas SAC Capital has not independently verified all the information set out in this report, all reasonable care and effort has been taken to ensure that the facts stated herein are accurate, this report might contain certain forward looking statements and forward looking financial information which are based on certain assumptions and involve known and unknown risks, uncertainties and other factors which may cause the actual results or performance of the subject company to be materially different from those expressed herein. Predictions, projections or forecasts of the economy or market trends are not indicative of the future performance of the subject company. The inclusion of such statements and information should not be regarded as a representation, warranty or prediction with respect to the accuracy of the underlying assumptions of the subject company or that the forecast results will or are likely to be achieved. Our opinion and facts set out in this report are based on the market, economic, industry and other applicable conditions prevailing as at the date of the preparation of this report. Such conditions may change significantly over a relatively short period of time and we assume no responsibility to update, revise or reaffirm our opinion in light of any development subsequent to the publication of this report, that may or may not have affected our opinion contained herein. This report may contain forward-looking statements, forecasts and projections that involve assumptions, risks and uncertainties. Actual result may differ materially from those express or implied. Such forward-looking statements are made only as of the date of this report and SAC Capital assumes no obligation to update or revise them to reflect new information or future events. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information or opinions contained herein. To the extent permitted by law, SAC Capital and its affiliates, officers, directors, employees and agents expressly disclaim any liability (including negligence) for any loss arising from the use of this report or its contents. SAC Capital and its connected persons (including officers, directors and employees) may have positions in, make markets in, or effect transactions in securities mentioned in this report, and may from time to time provide or solicit advisory, corporate finance, underwriting, placement, sponsorship or other services to the issuers of those securities. SAC Capital’s employees or connected persons serve on the board or trustee positions of the subject companies as disclosed hereunder: Name of the subject company Designation Nil Nil As at the date of this report, SAC Capital has proprietary positions or interests in the subject companies as disclosed hereunder: Party Quantum of position SAC Capital 209,827 shares 15 As at the date of this report, SAC Capital, has had business relations with the subject company within the past 12 months, as disclosed hereunder: Nature of Business Relation Date of Business Relation Catalist Sponsor May 2026 Placement Agent May 2026 Underwriting Agent June 2026 As at the date of this report, the analysts who covered the securities in this report have proprietary positions or material interests in the subject company covered as disclosed hereunder: Analyst name Quantum of position Nil Nil ANALYST CERTIFICATION As noted above, research analyst(s) of SAC Capital who produced this report hereby certify that (i) The views expressed in this report accurately reflect his/her personal views about the subject company; (ii) The report was produced independently by him/her; (iii) He/she does not on behalf of SAC Capital or any other person carry out other services involving any of the subject company or securities referred to in this report; and (iv) He/she has not received and will not receive any compensation or benefits related to the recommendations or views expressed in this report or to any sales, trading, dealing or corporate finance advisory services or transaction in respect of the securities in this report. He/she has not and will not receive any compensation or benefits linked to the performance of the securities of the subject company from the time of the publication of this report either.